CPCA HCPCS Coding for Injectables Questions and Answers

Question 1

A patient receives 28 units of onabotulinumtoxinA for the treatment of glabellar lines. The HCPCS Level II code is J0585, which is defined as 'Injection, onabotulinumtoxinA, 1 unit'. How should the supply of the drug be reported on the claim form?

Accepted Answer

J0585 with 28 units

Answer

The correct HCPCS code for onabotulinumtoxinA (Botox) is J0585. The code descriptor specifies '1 unit'. Therefore, if 28 units are administered, the number of units reported on the claim should be 28. J0588 is the code for incobotulinumtoxinA (Xeomin). The drug supply is billed separately from the administration procedure.

Question 2

A physician administers 2.5 mL of deoxycholic acid from a vial with a concentration of 10 mg/mL to reduce submental fat. The HCPCS code is J0591, which represents 'Injection, deoxycholic acid, 1 mg'. How many units of J0591 should be billed?

Accepted Answer

25

Answer

To determine the correct number of units, the total dosage in milligrams must be calculated. The patient received 2.5 mL of a 10 mg/mL solution, which equals 25 mg (2.5 mL x 10 mg/mL). Since the HCPCS code J0591 represents 1 mg of the drug, the correct number of units to bill is 25.

Question 3

When billing for an injectable drug using a J-code, which of the following pieces of information is essential to include on the claim form for many payers to ensure accurate processing and reimbursement?

Accepted Answer

The National Drug Code (NDC) of the product administered

Answer

For accurate claim processing and to meet the requirements of many payers, including state Medicaid agencies, the 11-digit National Drug Code (NDC) of the specific drug product administered must be reported on the claim. This allows for precise identification of the manufacturer, drug, strength, and package size, which is not captured by the HCPCS code alone.

Question 4

A provider uses a 100-unit single-dose vial of incobotulinumtoxinA (HCPCS J0588) to treat a patient. The provider administers 80 units and must discard the remaining 20 units. According to CMS guidelines, how should the discarded portion be billed?

Accepted Answer

Bill J0588 for 80 units on one line, and J0588 with the JW modifier for 20 units on a separate line.

Answer

When a portion of a drug from a single-dose vial is discarded, the JW modifier is used to report the wasted amount. The administered dose (80 units) should be billed on one claim line, and the discarded amount (20 units) should be billed on a separate claim line with the same HCPCS code (J0588) and the JW modifier appended.

Question 5

A physician administers a newly FDA-approved injectable biologic that does not yet have a specific HCPCS Level II code. Which of the following codes would be most appropriate to use for billing the drug supply?

Accepted Answer

J3590 (Unclassified biologics)

Answer

HCPCS code J3590 is designated for 'Unclassified biologics' and is the appropriate code to use when a specific code has not yet been assigned to a new biologic drug. J3490 is for unclassified drugs in general, but J3590 is more specific for biologics. J9999 is for chemotherapy drugs, C9399 is for hospital outpatient use, and 99070 is a CPT code for supplies not typically used for separately billable drugs.

CPCA Exam Practice Test

CPCA Exam Practice Test

CPCA HCPCS Coding for Injectables Questions and Answers